Leadership Overview
Penumbra has 5 executives leading key functions including strategy, finance, information technology, marketing, and international operations.
Driven by innovation, Penumbra is dedicated to advancing neurovascular therapies and improving patient outcomes through cutting-edge medical device technology, impacting global healthcare markets.
Driven by innovation, Penumbra is dedicated to advancing neurovascular therapies and improving patient outcomes through cutting-edge medical device technology, impacting global healthcare markets.
Leadership Roles at Penumbra
Adam Elsesser - Chief Executive Officer & Chairman of the Board
Adam Elsesser, the Chief Executive Officer & Chairman of the Board at Penumbra, directs the company's overarching strategy and governance. Elsesser guides Penumbra's mission to develop and deliver innovative neurovascular access and thrombectomy systems, ensuring alignment with market needs across the United States, Europe, Canada, Australia, Japan, and other international territories. This leadership role involves setting the strategic vision for product development, market expansion, and operational excellence, directly influencing the company's growth trajectory and its impact on patient care. Overseeing the executive team, Adam Elsesser ensures that all functional areas, from research and development to sales and marketing, operate cohesively to achieve corporate objectives. The Chairman of the Board's responsibilities include fostering a culture of innovation and accountability, driving long-term value for stakeholders, and maintaining the company's commitment to advancing medical technology. Through strategic decision-making, Elsesser champions the development of groundbreaking devices like the Neuron MAX and Penumbra System brands, solidifying Penumbra's position as a leader in the medical device industry.
Maggie Yuen - Chief Financial Officer
Maggie Yuen, the Chief Financial Officer at Penumbra, manages all financial operations and strategic financial planning. Yuen oversees budgeting, forecasting, capital allocation, and investor relations, ensuring the fiscal health and sustainable growth of the company across its global operations in the United States, Europe, Canada, Australia, and Japan. This critical role involves analyzing financial performance, identifying opportunities for cost optimization, and mitigating financial risks associated with product development and market expansion. Maggie Yuen works closely with other executive leaders to align financial strategies with the company's business objectives, particularly in the development and marketing of neurovascular access systems and thrombectomy devices. The Chief Financial Officer's oversight extends to financial reporting, compliance, and the management of financial systems that support Penumbra's manufacturing and international distribution networks. By providing robust financial insights, Yuen enables informed decision-making, supporting Penumbra's commitment to innovation and its market leadership in medical technology.
James Pray - President, International
James Pray, the President, International at Penumbra, leads the company's strategic expansion and operational management across all global markets outside the United States. Pray oversees sales, distribution, and business development initiatives in Europe, Canada, Australia, Japan, and other international territories, driving revenue growth and market penetration for Penumbra's neurovascular access systems and thrombectomy devices. This executive role involves building and managing international teams, establishing key partnerships, and ensuring compliance with diverse regulatory environments. James Pray works closely with the executive leadership team to tailor market strategies to regional needs, maximizing the impact of products like the Neuron MAX and Penumbra System brands. The President, International's responsibilities include identifying new market opportunities, optimizing supply chain logistics for global distribution, and fostering strong customer relationships worldwide. Through strategic leadership, Pray ensures Penumbra's commitment to advancing medical technology reaches patients and healthcare providers across the globe.
Pankaj Tiwari - Executive Vice President & Chief Information Officer
Pankaj Tiwari, the Executive Vice President & Chief Information Officer at Penumbra, directs the company's information technology strategy and infrastructure. Tiwari oversees the development and implementation of technology solutions that support Penumbra's global operations, including its design, development, manufacturing, and marketing of medical devices across the United States, Europe, Canada, Australia, and Japan. This leadership position involves managing enterprise systems, cybersecurity, data management, and digital transformation initiatives to enhance operational efficiency and innovation. Pankaj Tiwari collaborates with executive peers to ensure technology investments align with business goals, particularly in areas supporting product lifecycle management and market access for neurovascular therapies. The Chief Information Officer's responsibilities include safeguarding sensitive company and patient data, optimizing IT resources, and driving technological advancements that empower research and development efforts. By ensuring robust and secure IT systems, Tiwari underpins Penumbra's ability to deliver cutting-edge medical devices and maintain its competitive edge in the international healthcare market.
Venkat Tummala - Associate Chief Marketing Officer
Venkat Tummala, the Associate Chief Marketing Officer at Penumbra, drives marketing strategies and brand initiatives across global markets. Tummala oversees the development and execution of campaigns that promote Penumbra's innovative neurovascular access systems and thrombectomy devices, including the Neuron, Penumbra System, and 3D brands, in the United States, Europe, Canada, Australia, and Japan. This role focuses on enhancing market presence, communicating product value propositions, and supporting sales efforts through targeted marketing activities. Venkat Tummala collaborates with product development and sales teams to ensure marketing messages accurately reflect the technological advancements and clinical benefits of Penumbra's medical devices. The Associate Chief Marketing Officer's responsibilities include market research, competitive analysis, and the strategic positioning of Penumbra's portfolio to capture market share and drive revenue growth. By leading impactful marketing efforts, Tummala contributes significantly to Penumbra's mission of improving patient outcomes through advanced medical technology and expanding its reach internationally.
Explore Leadership Teams in Manufacturing
Since 1997, the journey of Trivitron Healthcare as a medical technology company providing affordable healthcare solutions weaves a fascinating thread of inspiration to many healthcare providers. Having a solid expertise in research and development, Trivitron manufactures and distributes exceptional medical technology products.
Company Leadership RS
PP
SS
BM
Globus Medical, Inc. is a leading musculoskeletal solutions company and is driving significant technological advancements across a complete suite of products. Founded in 2003, Globus single-minded focus on advancing surgery has made it the fastest growing company in the history of orthopedics. Globus is driven to utilize superior engineering and technology to achieve pain free, active lives for all patients.
Company Leadership
KK
NJ
Established in 2018, ALPS is headquartered in Singapore. They bring together healthcare supply chain professionals to meet the procurement and supply chain needs of the healthcare system.
Company Leadership LG
WY
GC
MW
Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.
Company Leadership JR
MM
Frequently Asked Questions Regarding Penumbra Top Executives and Leadership Team
Unlock more people and company data
